Large intergenic non-coding RNA-ROR reverses gemcitabine-induced autophagy and apoptosis in breast cancer cells

Oncotarget. 2016 Sep 13;7(37):59604-59617. doi: 10.18632/oncotarget.10730.

Abstract

The purpose of this study was to elucidate the potential role of long intergenic non-protein coding RNA, regulator of reprogramming (linc-ROR) in gemcitabine (Gem)-induced autophagy and apoptosis in breast cancer cells. MDA-MB-231 cells were treated with short hairpin RNA (shRNA) to knockdown Linc-ROR expression in the presence of Gem. Gem treatment alone decreased cell survival and increased both apoptosis and autophagy. Gem treatment also increased the expression of LC3-II, Beclin 1, NOTCH1 and Bcl-2, but decreased expression of p62 and p53. Untreated MDA-MB-231 cell lines strongly expressed linc-ROR, but linc-ROR knockdown decreased cell viability and expression of p62 and p53 while increasing apoptosis. Linc-ROR knockdown also increased LC3-II/β-actin, Beclin 1, NOTCH1, and Bcl-2 expression, as well as the number of autophagic vesicles in MDA-MB-231 cells. Linc-ROR negatively regulated miR-34a expression by inhibiting histone H3 acetylation in the miR-34a promoter. We conclude that linc-ROR suppresses Gem-induced autophagy and apoptosis in breast cancer cells by silencing miR-34a expression.

Keywords: breast cancer; gemcitabine; large intergenic non-coding; linc-ROR.

MeSH terms

  • Antimetabolites, Antineoplastic / pharmacology
  • Apoptosis / drug effects*
  • Apoptosis / genetics
  • Autophagy / drug effects*
  • Autophagy / genetics
  • Breast Neoplasms / genetics
  • Breast Neoplasms / pathology
  • Cell Line
  • Cell Line, Tumor
  • Cell Survival / drug effects
  • Cell Survival / genetics
  • Deoxycytidine / analogs & derivatives*
  • Deoxycytidine / pharmacology
  • Gemcitabine
  • Gene Expression Regulation, Neoplastic*
  • Gene Knockdown Techniques
  • Histones / metabolism
  • Humans
  • Methylation
  • MicroRNAs / genetics*
  • Promoter Regions, Genetic / genetics
  • RNA, Long Noncoding / genetics*

Substances

  • Antimetabolites, Antineoplastic
  • Histones
  • Linc-RNA-RoR, human
  • MIRN34 microRNA, human
  • MicroRNAs
  • RNA, Long Noncoding
  • Deoxycytidine
  • Gemcitabine